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Background. A prospective randomised controlled trial comparing gamete intrafallopian transfer (GIFT) with 
intrauterine insemination (IUI) was undertaken at the Fertility and Reproductive Biology Unit of the Department 
of Obstetrics and Gynaecology, Tygerberg Hospital, between July 1999 and June 2000. 
Method. Eighty-five women were included in the study and were randomly allocated between the two groups 
after routine infertility investigations, 41 women to IUI and 44 women to GIFT. A combination of clomiphene 
citrate and human menopausal gonadotropin was administered to both groups to achieve ovulation. 
Results. Six (13.6%) of the 44 cycles in the IUI group and 24 (53.3%) of the 45 cycles in the GIFT group achieved 
conception.  The mean number of cycles needed to achieve pregnancy in IUI was 7.3 (44/6) and in GIFT was 
2.05 (45/24). The ongoing pregnancy rate of GIFT was 39.7% more effective than that of IUI (p=0.0001.The total 
ongoing pregnancy rate of GIFT was 30.8% superior to that of IUI (p=0.0021). When 2 follicles were obtained in 
an IUI cycle, GIFT was 41.6% more effective (p=0.0024), and when more than 2 follicles were obtained, GIFT was 
28.3% more effective (p=0.0265).  
Conclusions. The number of mature follicles significantly increased the chance of pregnancy with IUI. In 
comparing the number of cycles needed to achieve a pregnancy, 1 GIFT cycle is equivalent to more than 3 IUI 
cycles. It is important to note that 4 IUI cycles will give equivalent or even better results if 2 - 3 follicles are 
recruited per cycle. In spite of the greater efficacy of GIFT, the authors conclude that at least 3 to 4 IUI cycles 
should be attempted before GIFT, on the basis that it is more cost effective and less invasive. 
Although artificial insemination is one of the oldest and 
most commonly used infertility treatments, data remain 
uncertain on the optimal timing of insemination, the 
number of insertions and the effect of single versus 
double regimens.1 The rationale for controlled super-
ovulation and intrauterine insemination (IUI) involves 
the implicit assumption that the ova are being released 
by the ovary, picked up by the fallopian tubes and 
that motile sperm reach the ova in concentrations 
adequate to achieve fertilisation.2 IUI with or without 
controlled ovarian hyperstimulation is the treatment 
entity nearest to the natural form of procreation. It 
is a less sophisticated procedure, associated with 
minimum discomfort and trauma, and is essentially 
more affordable. For these reasons, in many reproductive 
health care institutions it is often the first line of 
treatment offered to couples with idiopathic infertility, 
male factor infertility, and hostile cervical mucus and 
anti-sperm antibodies.3
Gamete intrafallopian transfer (GIFT) was first reported 
in 1984 by Asch et al.4 as an alternative to in vitro 
fertilisation (IVF), in an attempt to overcome some of the 
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unaddressed assumptions of IUI. Initially, laparoscopy 
formed an integral part of the procedure, both in the 
harvesting of ova and in reintroducing them, combined 
with sperm, into the fallopian tube. It is a technique 
aimed at reproducing a physiological step in natural 
fertilisation and possibly ameliorating the implantation 
rate of other assisted reproductive technique (ART) 
programmes. The hypothesis is that the role of the 
oviduct might not only be mechanical by allowing 
gamete and embryo transport, but physiological as 
well, in providing nutrients and other factors important 
in embryo development. Increased exposures to 
progesterone and growth factors are some of the most 
important issues currently being evaluated.5 Because 
of the invasive nature of laparoscopy, GIFT has become 
increasingly unpopular in comparison with other ART, 
like IVF and intracytoplasmic sperm injection (ICSI). In 
an attempt to circumvent laparoscopy, techniques such 
as transvaginal ova aspiration and transcervical GIFT 
have been evaluated.6 
In a prospective non-randomised study comparing 
various ART by Mills et al.,7 the authors observed that the 
pregnancy rate in GIFT (40%) was the highest, followed 
by IVF (28%) and IUI (13%). However, the implantation 
rate per egg transferred by GIFT (21%) was reported 
to be significantly better than the implantation rate 
per embryo transferred by IVF (11%). They concluded 
that the lower pregnancy rates in IUI cycles were to be 
expected because of limited ovarian stimulation.
The supremacy of GIFT was reaffirmed in a cohort 
study and meta-analysis by Peterson et al.8 comparing 
ovulation induction with gonadotropin and IUI to IVF 
or no therapy. They concluded that the pregnancy 
rate for one cycle of ovarian stimulation and IUI was 
inferior to pregnancy rates associated with IVF, GIFT or 
zygote intra-fallopian transfer (ZIFT).  Two cycles were 
equivalent to IVF or ZIFT but inferior to GIFT.  Three 
cycles were superior to IVF or ZIFT and equivalent to 
GIFT and four cycles superior to all techniques. 
A study by Yovich and Matson9 also confirmed a 
significantly better pregnancy rate with GIFT compared 
with IUI. In contrast to these findings, a prospective 
study looking at IUI and intraperitoneal insemination, 
with controlled ovulatory hyperstimulation alone, 
in comparison with GIFT revealed that IUI was as 
effective as GIFT.  Hogerzeil et al.10 noted no significant 
difference in pregnancy rate between two GIFT cycles 
and two ovarian stimulation, IUI cycles.
In an attempt to understand the place and efficacy 
of various artificial reproductive techniques, we have 
embarked on a study comparing GIFT and IUI, on the 
basis of the closer correlation of these two techniques 
compared with that of other ART techniques such as 
IVF and ICSI. The aim of this study, therefore, is to 
compare the pregnancy outcome of IUI and GIFT in a 
prospective randomised controlled approach. 
Materials and methods
During the period 1 July 1999 to 30 June 2000, 85 
couples presenting to the Fertility and Reproductive 
Biology Unit at Tygerberg Hospital with idiopathic 
infertility were included in a prospective randomised 
controlled study.  All women in the reproductive age 
group with a minimum duration of infertility of 3 years 
were included and randomised according to random 
tables into two groups, namely IUI or GIFT.
Infertility evaluation 
Male partner 
A semen analysis was performed on the male partner 
with semen samples obtained at the laboratory after 3 
to 4 days of abstinence. The assessment of the sample 
was done according to the Tygerberg criteria.11 A 
spermatozoon was considered normal when the head 
had a smooth oval configuration and a well-defined 
acrosome that comprised approximately 40 - 70% of the 
sperm head. In addition, the sperm should have no neck, 
midportion or tail defects, and the cytoplasmic droplets 
should not be larger than one half the size of the sperm 
head. All morphology groups were accepted into this 
study. If screening for antibodies had not been done 
before entry into the programme, a mixed erythrocyte-
spermatozoa antiglobulin test (MAR test) was done as 
a screening procedure to exclude male immunological 
infertility.  The direct immunobead test (DBT) was 
used to confirm sperm-bound immunoglobulin IgA and 
IgG.12   
Female partner 
The sperm-cervical mucus contact test was conducted 
as a screening procedure in all the female patients to 
exclude a female immunological infertility factor. The 
indirect immunobead test (IBT) was done to confirm 
the presence of antibodies in the cervical mucus. 
Menstrual fluid samples were collected and sent for 
Mycobacterium tuberculosis cultures. Cervical cultures 
for Ureaplasma urealyticum were routinely taken, and 
if positive, the patient was treated with tetracycline 
(400 mg 8-hourly for 5 days) before the fertility 
procedure. A hysterosalpingogram or hysteroscopy 
and laparoscopy were performed to determine tubal 
patency and to exclude uterine cavity abnormalities 
and pelvic adhesions.  All patients had an ultrasound 
scan prior to the treatment offered and the condition of 
the ovaries and uterus was noted.
Ovarian stimulation 
Using a combination of clomiphene citrate and human 
menopausal gonadotropin, ovarian hyperstimulation 
was achieved in all patients.13  Patient follow-up 
consisted of serum luteinising hormone and estradiol 
determinations, as well as serial ultrasonographic 
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measurement of the graafian follicle and endometrial 
thickness.  Human menopausal gonadotropin (hMG) 
was administered as soon as the leading follicle reached 
a diameter of 18 mm. Follicle aspiration was performed 
36 hours later. 
In the case of the IUI cohort, 50 mg of clomiphene 
citrate was administered from day 4 to day 8 of each 
cycle, with one ampoule of hMG on days 4, 6 and 8.
In the GIFT cohort the clomiphene citrate dose was 100 
mg per day, with two ampoules of hMG administered 
every alternate day starting on the 4th day of the 
cycle. 
Semen preparation 
On the day of the GIFT/IUI procedure (36 - 42 hours 
after hMG administration), the spouse was asked to 
produce a semen sample 1½ hours before laparoscopy/
IUI.  The semen was prepared according to the double 
wash and swim-up technique.14
Gamete intrafallopian transfer 
Laparoscopy and follicle aspiration was performed under 
general anaesthesia.  One hundred per cent CO2 was 
used to create the pneumoperitoneum.  The aspirated 
oocytes were evaluated for maturity and classified 
according to the criteria described by Veeck15 as being 
either metaphase I or II. Three oocytes were randomly 
selected on completion of follicle aspiration. Patients 
in whom less than 3 oocytes were obtained during 
aspiration were excluded from the study. Oocytes were 
loaded into the transfer catheter together with 100 000 
sperm.  The number of sperm was increased to 500 000 
if the male partner had a morphology of less than 14% 
normal forms on semen analysis.16 The loaded catheter 
was passed through the cannula used for aspiration and 
then inserted into the fallopian tube up to a distance 
of 2 cm from the fimbrial opening, where the gametes 
were deposited.  All excess oocytes were fertilised in 
vitro and embryos were frozen at the eight-cell stage 
for future replacement.
Intrauterine insemination 
Patients with more than 3 follicles were excluded 
from the study.  Inseminations were performed with 
an Edwards-Wallace Embryo Replacement Catheter® 
(Simcare and SIMS ref. 1816).  The inseminate, 
suspended in 1 ml of standard medium, was slowly 
injected high up into the uterine cavity.  The patient 
rested for 10 minutes before resuming normal activity. 
Diagnosis of pregnancy 
The conception rate in this study included all 
biochemical pregnancies and conception was diagnosed 
if the serum β-hCG was positive on day 12 and if the 
values had doubled on day 16 after insemination.  The 
ongoing pregnancy rate was defined as the number of 
pregnancies that reached a viable gestational age of 
28 weeks.  
Statistical analysis
In an intention-to-treat analysis, the conception rate 
and the ongoing pregnancy rate in the two arms of the 
trial were compared by means of Fisher’s exact test for 
the difference in proportions. The absolute difference 
between the proportions was estimated as well as the 
95% confidence intervals (CIs) for reporting the effect 
size of the trial.
The conception rate in specific subgroups relating to 
the number of follicles observed in the IUI arm was also 
compared to the GIFT arm with Fisher’s exact test. The 
analysis was done using the statistical analysis system 
(SAS).17
The easiest way to correlate the two entities is in the 
number needed to treat (NNT), in this case the number 
of cycles to attain pregnancy. 
Results
The mean age of the female partners in the IUI group 
was 32 years (range 27 - 38 years). The total number of 
women involved was 41 and a total number of 44 cycles 
was attempted. The conception rate achieved with 
IUI was 13.6% (6/44) and the ongoing pregnancy rate 
per cycle was 6.8% (3/44).  The conception rate with 
2 follicles per cycle was 11.8% (2/17), and with more 
than 2 follicles per cycle the rate was 25% (4/16). No 
pregnancies resulted when a single follicle per cycle 
was achieved. There was one tubal pregnancy and 5 
intrauterine pregnancies, of which 4 were singleton 
pregnancies and 1 multiple.  Three of the intrauterine 
singleton pregnancies resulted in 2 female babies and 
1 male baby, while the twins and the other singleton 
pregnancy aborted at 16 and 8 weeks’ gestation 
respectively.  The rate of twinning was 1/6 (16.7%), the 
miscarriage rate was 2/6 (33.33%) and the rate of tubal 
pregnancies was 1/6 (16.7%) (Table I).
In the GIFT group, the mean age of the female 
partners was 34 years (22 - 40). The total number of 
women involved was 44 and a total of 45 cycles were 
attempted. The conception rate achieved with GIFT 
was 53.3% (24/45), and the ongoing pregnancy rate per 
cycle was 35.6% (16/45). There were 23 intrauterine 
pregnancies and 1 tubal pregnancy.  Among the 
intrauterine pregnancies, there were 3 sets of twins 
and 13 singletons (a total 19 babies, 8 females and 
11 males).  The rate of twining was 12.5% (3/24), the 
miscarriage rate was 19.17% (7/24) and the rate of tubal 
pregnancies was 4.17% (1/24) (Table II).
To correlate the two entities we used number needed to 
treat (NNT) to achieve a pregnancy and the effect size 
as an estimation of efficacy between the two entities. 
The number of cycles needed to achieve pregnancy in 
IUI was 7.3 (44/6) and in GIFT it was 2.05 (45/24). It can 
therefore be concluded that on average one would need 
5 extra IUI cycles to compare to 2 GIFT cycles to achieve 
pregnancy. Looking at the relationship between GIFT 
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and IUI (7.3/2.05=3.6), 1 GIFT cycle would therefore be 
proportional to 3.6 IUI cycles.
The effect size, as illustrated in Table III, is an indicator 
of how much more effective GIFT is in comparison 
with IUI. The ongoing pregnancy rate of GIFT is 39.7% 
more effective than that of IUI, with a p-value of 0.0001, 
and the total ongoing pregnancy rate is 30.8% more 
superior to that of IUI, with a p-value of 0.0021. When 2 
follicles were achieved in an IUI cycle, GIFT was 41.6% 
more effective (p-value 0.0024) and when more than 2 
follicles were achieved, GIFT was 28.3% more effective 
(p-value 0.0265) (Table III).
Discussion  
Despite the large amount of published information on 
the topic of assisted reproduction there are surprisingly 
few data from well-planned prospective randomised 
investigations. Although results published from such 
studies often proclaim the superiority of a particular 
technique, the proliferation of uncontrollable and 
sometimes unknown confounding variables suggests 
that the findings should be viewed with caution. On the 
relatively few occasions when a more rigorous approach 
has been followed, it is surprising how difficult it has 
been to produce evidence of the differential efficacy of 
the assisted reproduction methods in current use.18
We therefore embarked on a study of comparing IUI 
and GIFT in a prospective randomised controlled 
approach, on the basis of the closer relationship of 
these two techniques compared with that of IVF. The 
hypothesis was that the role of the oviduct might not 
only be mechanical by affording gamete and embryo 
transport, but probably has a physiological role in 
providing nutrients and other factors important in 
embryo development.5 
Many earlier studies have confirmed the superiority 
of the GIFT procedure over all assisted reproductive 
methods in couples where there is unexplained and 
male-related subfertility but evidence of normal fallopian 
tubes.7,11,19-23 In contrast, the retrospective analysis 
by Dodson et al.24 showed that super-ovulation with 
intrauterine insemination approached the fecundity 
of normal women, and equalled or exceeded that 
reported for IVF-ET and GIFT. However,  all authors 
recommended randomised controlled trials to compare 
and demonstrate the efficacy of super-ovulation with 
intrauterine insemination and GIFT procedures and 
favour attempts at IUI before the more invasive and 
expensive procedures of ART.
The relationship between GIFT and IUI revealed that 
one GIFT cycle would be proportional to 3.6 IUI 
cycles. This compares well with a cohort study and 
meta-analysis by Peterson et al.8 comparing ovulation 
induction with gonadotropin and IUI, to IVF or no 
therapy. They concluded that the pregnancy rate for 
one cycle of (hMG) ovarian stimulation and IUI was 
inferior to pregnancy rates associated with IVF, GIFT 
or ZIFT; 2 IUI cycles were equivalent to IVF or ZIFT but 
inferior to GIFT, 3 cycles were superior to IVF or ZIFT 
and equivalent to GIFT and 4 cycles were superior to all 
techniques. The conclusion was therefore made that at 
No. of follicles Conception rate per cycle Ongoing pregnancy rate (>28 wks)
1 0/11 (0%) 0/11 (0%)
2 2/17 (11.8%) 1/17 (5.9%)
>2 4/16 (25%) 2/16 (8%)
 6/44 (13.6%) 3/44 (6.82%)
 Subdivision of pregnancies
 Singletons born Sets of twins born Miscarriages Tubal
Pregnancy outcome 3/6     (50%) 0/6     (0%) 2/6     (33.3%) 1/6     (16.7%)
   1 singleton
   1 set twins 
Table I.   Pregnancy rate according to the number of follicles achieved with IUI
No. of women Conception rate per cycle Ongoing pregnancy rate (>28 wks)
44 24/45 (53.3%) 16/45 (35.6%)
 Subdivision of pregnancies
 Singletons born Sets of twins born Miscarriages Tubal
Pregnancy outcome 13/24 (54.17%) 3/24 (12.5%) 7/24 (29.17%) 1/24 (4.17%)
Table II.    Pregnancy rate achieved with GIFT
Gift v. IUI Effect size (95% CI) p-value
Conception rate 39.7% (20.4 - 55.2%) 0.0001
Ongoing pregnancy rate 30.8% (12 - 46.9%) 0.0021
>2 follicles 28.3% (0 - 48.5%) 0.0265
2 follicles 41.6% (14.9 - 57.7%) 0.0024
Table III.    Effectiveness of GIFT in comparison with IUI as illustrated in effect size and its associated 
power
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least 4 cycles of IUI are indicated before embarking on 
the application of more advanced assisted reproductive 
techniques, and we support this statement based on 
the data represented in our study.
An additional important finding of this study was that 
the pregnancy rate in the IUI procedure significantly 
improved as the number of mature follicles increased. 
The pregnancy rate with 2 follicles per cycle was 11.8% 
and the pregnancy rate with more than 2 follicles per 
cycle was 25% for these subgroups. No pregnancies 
resulted when a single follicle per cycle was achieved. 
The difference was still significant in favour of GIFT, 
in terms of pregnancy outcome, independent of the 
number of follicles achieved in IUI (Table III). This 
finding should motivate clinicians to try to achieve 
well-controlled ovulation induction with 2 but not more 
than 4 follicles to achieve maximum benefit from IUI 
attempts. There was no statistical significance between 
the two groups regarding the miscarriage rate, rate of 
tubal pregnancies and rate of multiple pregnancies.
In conclusion, this prospective randomised controlled 
clinical trial has demonstrated that GIFT is superior 
to IUI in relation to pregnancy outcome. However, it is 
important to note that 4 IUI cycles will give equivalent 
or even better results if 2 - 3 follicles are recruited per 
cycle. In view of the fact that IUI is a non-invasive 
procedure, it should be strongly considered as a first-
line approach in the management of selected infertile 
couples.
  1. Alborzi S, Motazedian S, Parsanezhad ME, Jannati S. Comparison of the 
effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in 
infertility patients. Fertil Steril 2003; 80: 595-599.
  2. Guzick DS, Sullivan MW, Adamson GD, et al. Efficacy of treatment for unexplained 
infertility. Fertil Steril 1998; 70: 207-213.
  3. Waardt J, Kruger TF, Lombard CJ, Ombelet W. Predictive value of normal sperm 
morphology in intrauterine insemination (IUI): a structured literature review. Hum 
Reprod 2001; 7: 495-500.
  4. Asch RH, Balmaceda JP, Ellsworth LR, Wong PC. Gamete intrafallopian transfer 
(GIFT): a new treatment for infertility. Int J Fertil 1985; 2: 1034.
  5. Hannoun A, Abu-Musa A. Gamete intrafallopian transfer (GIFT) in the treatment of 
severe male infertility. Int J Gynaecol Obstet 1998; 61: 293-295.
  6. Sallam HN, Agamia AF, Sallam AN, Ezzeldin F. Transcervical gamete intrafallopian 
transfer versus controlled ovarian hyperstimulation and intrauterine insemination 
in the treatment of unexplained infertility. Fertil Steril 1997; 68: 72-73.
  7. Mills MS, Eddowes HA, Cahill DJ, et al.  A prospective controlled study of in vitro 
fertilization, gamete intrafallopian transfer and intrauterine insemination combined 
with super ovulation. Hum Reprod 1992; 7: 490-494.
  8. Peterson CM, Hatasaka HH, Jones KP, et al. Ovulation induction with gonadotropins 
and intrauterine insemination compared with in vitro fertilization and no therapy: a 
prospective non-randomized, cohort study and meta-analysis. Fertil Steril 1994;62: 
535-544. 
  9. Yovich JL, Matson PL. Pregnancy rate after high intrauterine insemination of 
husband’s spermatozoa or gamete intrafallopian transfer.  Lancet 1986; 2: 1287.
10. Hogerzeil HV, Spiekerman CM, De Vries JWA, et al.  A randomized trial between 
GIFT and ovarian stimulation for the treatment of unexplained infertility and failed 
artificial insemination by donor.  Hum Reprod 1992; 7: 1235.
11. Kruger TF,  Menkveld R,  Stander FSH,  et al.  Sperm morphologic features as a 
prognostic factor in, in vitro fertilization.  Fertil Steril 1986; 46: 1118-1123.
12. Menkveld R, Stander FSH, Kotze TJ, Kruger TF, van Zyl JA. The evaluation of 
morphological characteristics of human spermatozoa according to the stricter 
criteria. Hum Reprod 1990; 5: 589-592.
13. Van Der Merwe JP, Kruger TF, Swart Y, Lombard CJ. The role of oocyte maturity in 
the treatment of infertility because of teratozoospermia and normozoospermia with 
gamete intrafallopian transfer.  Fertil Steril 1992; 58(3): 581-586.
14. Kruger TF, Acosta AA, Simmons K, Swansons RJ, Matta J, Oehninger S.  Predictive 
value of abnormal sperm morphology in vitro fertilization.  Fertil Steril 49: 112-117. 
15. Veeck LL.  Abnormal morphology of the human oocyte and conceptus.  In:  Atlas 
of the Human Oocyte and Early Conceptus. New York: Parthenon Publishing, 1999: 
57-68.
16. Oehninger S,  Acosta AA,  Morshedi M,  et al.  Corrective measures and 
pregnancy outcome in vitro fertilization in patients with severe sperm morphology 
abnormalities.  Fertil Steril 1988; 50: 283-287.
17. SAS Institute Inc. SAS/STAT Users Guide, Version 8. Cary, NC: SAS Institute Inc., 
1999. www.sas.com 
18. Crosignani PG, Walters GE, Soliani A. The ESHRE multicenter trial on the treatment 
of unexplained infertility: a preliminary report. Hum Reprod 1991; 6: 963-968.
19. Kenny DT. In vitro fertilization and gamete intrafallopian transfer: an integrative 
analysis of research, 1987-1992. BJOG 1995; 102: 317-325.
20. Leeton J, Rogers P, Caro C, Healey D, Yates C. A controlled study between the 
use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo 
transfer in the management of idiopathic and male infertility. Fertil Steril 1987; 48: 
605-612.
21. Tanbo T, Dale PO, Abyholm T. Assisted fertilization in infertile women with patent 
fallopian tubes. A comparison of in vitro fertilization, gamete intrafallopian transfer 
and tubal embryo stage transfer. Hum Reprod 1990; 5: 266-270.
22. Ranieri M, Becket VA, Marchant S, et al. Gamete intrafallopian transfer or in 
vitro fertilization after failed ovarian stimulation and intrauterine insemination in 
unexplained infertility. Hum Reprod 1995; 10: 2033-2036.
23. Abyholm T, Tanbo T, Date PO, et al. In vitro fertilization procedures in infertile 
women with patent fallopian tubes: a comparison of gamete intrafallopian transfer, 
combined intrauterine and intraperitoneal insemination and controlled ovarian 
hyperstimulation alone. J Assist Reprod Genet 1992; 9:19-23.
24. Dodson WC, Whitesides DB, Hughes CL Jr, Early HA 3d, Haney AF. Super ovulation 
with intrauterine insemination in the treatment of infertility: a possible alternative 
to gamete intrafallopian transfer and in vitro fertilization.  Fertil Steril 1987; 48(3): 
441-445.
Alternative?
A Dutch doctor has been struck off the medical register 
for treating a patient with breast cancer by alternative 
care.  An actor and comedian, Sylvia Millecam had a 
lump in her breast diagnosed as cancer.  It measured 
3 - 4 cm but she did not want conventional treatment, 
so the doctor in question used magnetic field therapy 
and other alternative cures for 6 months, by which 
time the tumour had more than doubled in size.  She 
died in less than a year.
He argued that if he had insisted on oncological 
treatment his patient would have been ‘lost’ to follow-
up.  He kept inadequate notes and prevented her 
from having mainstream medical opinion. He was 
originally given a 6-month suspended sentence but 
appealed, only to be struck off the medical register for 
life (Sheldon, BMJ 2007; 335: 13).
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